Dosage and administration of antierbb3 antibodies in combination with tyrosine kinase inhibitors.
PK201200374A0Undetermined Publication Date: 2012-07-11MERRIMACK PHARMACEUTICALS INC +1
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- MERRIMACK PHARMACEUTICALS INC
- Filing Date
- 2012-06-13
- Publication Date
- 2012-07-11
Need to check novelty before this filing date? Find Prior Art
No text content released.